Assenagon Asset Management
BLUE

Assenagon Asset Management’s bluebird bio BLUE Stock Holding History

Assenagon Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,320
Closed -$419K – 1469
2022
Q1 		$419K Hold
4,320
– – ﹤0.01% 1241
2021
Q4 		$863K Sell
4,320
-9,900
-70% -$2.34M ﹤0.01% 1076
2021
Q3 		$3.52M Buy
+14,220
New +$4.07M 0.01% 522

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Assenagon Asset Management's BLUE Position: Q2 2022 in Review

Assenagon Asset Management sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 4,320 shares — an estimated $419K sold.

Assenagon Asset Management first reported a position in BLUE in Q3 2021 and held it in 3 quarters. The position peaked at $3.52M in Q3 2021. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • Assenagon Asset Management reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 4,320 bluebird bio shares in Q2 2022, an estimated $419K.
  • Assenagon Asset Management first reported a position in bluebird bio in Q3 2021 and held it in 3 quarters.
  • Assenagon Asset Management's bluebird bio position peaked at $3.52M in Q3 2021.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Assenagon Asset Management's 13F filing for Q2 2022, filed 27 Jul 2022.